Avanos Medical, Inc. (AVNS) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$5,431
Total Return
-45.69%
CAGR
-11.49%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -1.38% |
| Median | -1.93% |
| Best | +79.91% |
| Worst | -26.18% |
| % of Windows Positive | 41.9% |
1-Year (252 Trading Days)
| Average | -21.06% |
| Median | -20.40% |
| Best | +98.15% |
| Worst | -58.36% |
| % of Windows Positive | 8.0% |
3-Year (756 Trading Days)
| Average | -48.91% |
| Median | -51.45% |
| Best | -19.69% |
| Worst | -65.14% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -78.37% |
| Average Drawdown | -49.60% |
| Drawdown Duration | 1254 Trading Days (Unrecovered) |
| Sortino Ratio | -0.07 |
| Calmar Ratio | -0.15 |
| CVaR (5%) | -5.41% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +119.32% (+1477.24% ann.) | +$11932.37 | $0.00 | $0.00 | $0.00 |
| 2025 | -29.46% | $2946.00 | $0.00 | $0.00 | $0.00 |
| 2024 | -29.02% | $2902.35 | $0.00 | $0.00 | $0.00 |
| 2023 | -17.11% | $1711.02 | $0.00 | $0.00 | $0.00 |
| 2022 | -21.95% | $2194.98 | $0.00 | $0.00 | $0.00 |
| 2021 | -24.43% | $2443.33 | $0.00 | $0.00 | $0.00 |
| 2020 | +36.14% | +$3614.24 | $0.00 | $0.00 | $0.00 |
| 2019 | -24.76% | $2476.00 | $0.00 | $0.00 | $0.00 |
| 2018 | -3.01% | $300.99 | $0.00 | $0.00 | $0.00 |
| 2017 | +24.88% | +$2487.83 | $0.00 | $0.00 | $0.00 |
| 2016 | +10.69% | +$1068.54 | $0.00 | $0.00 | $0.00 |
| 2015 | -26.52% | $2652.30 | $0.00 | $0.00 | $0.00 |
| 2014 partial | +10.90% (+70.29% ann.) | +$1090.24 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | October 21, 2014 – February 19, 2020 | -24.12% | -5.05% | $2412.19 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -32.99% | -98.96% | $3298.69 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +71.23% | +137.60% | +$7123.18 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -25.37% | -24.24% | $2537.35 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -19.72% | -20.80% | $1972.16 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -6.47% | -3.54% | $646.79 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +1.73% | +1.10% | +$173.48 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.